Join
Live feed
·
INSIDERFilingvia Quantisnow
Inhibrx Biosciences Inc. logo

Chief Executive Officer Lappe Mark bought $671,150 worth of shares (44,000 units at $15.25) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INBX (Inhibrx Biosciences Inc.) and more on Quantisnow.

Chief Executive Officer Lappe Mark bought $671,150 worth of shares (44,000 units at $15.25) (SEC Form 4) | Quantisnow